Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 247

1.

miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.

Minacapelli CD, Bajpai M, Geng X, Van Gurp J, Poplin E, Amenta PS, Brant SR, Das KM.

Inflamm Bowel Dis. 2018 Sep 11. doi: 10.1093/ibd/izy279. [Epub ahead of print]

PMID:
30204869
2.

Colorectal cancer prevention in patients with ulcerative colitis.

Lopez A, Pouillon L, Beaugerie L, Danese S, Peyrin-Biroulet L.

Best Pract Res Clin Gastroenterol. 2018 Feb - Apr;32-33:103-109. doi: 10.1016/j.bpg.2018.05.010. Epub 2018 May 16. Review.

PMID:
30060933
3.

Mangosteen Extract Prevents Dextran Sulfate Sodium-Induced Colitis in Mice by Suppressing NF-κB Activation and Inflammation.

Chae HS, You BH, Song J, Ko HW, Choi YH, Chin YW.

J Med Food. 2017 Aug;20(8):727-733. doi: 10.1089/jmf.2017.3944. Epub 2017 Jun 27.

PMID:
28654307
4.

Kaposi Sarcoma Mimicking Acute Flare of Ulcerative Colitis.

Kumar V, Soni P, Garg M, Abduraimova M, Harris J.

J Investig Med High Impact Case Rep. 2017 Jun 12;5(2):2324709617713510. doi: 10.1177/2324709617713510. eCollection 2017 Apr-Jun.

5.

Inflammatory bowel disease in liver transplanted patients.

Filipec Kanizaj T, Mijic M.

World J Gastroenterol. 2017 May 14;23(18):3214-3227. doi: 10.3748/wjg.v23.i18.3214. Review.

6.

Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.

Pulusu SSR, Lawrance IC.

Expert Rev Gastroenterol Hepatol. 2017 Aug;11(8):711-722. doi: 10.1080/17474124.2017.1327347. Epub 2017 May 16. Review.

PMID:
28475382
7.

Oxidized 5-aminosalicylic acid activates Nrf2-HO-1 pathway by covalently binding to Keap1: Implication in anti-inflammatory actions of 5-aminosalicylic acid.

Kang S, Kim W, Jeong S, Lee Y, Nam J, Lee S, Jung Y.

Free Radic Biol Med. 2017 Jul;108:715-724. doi: 10.1016/j.freeradbiomed.2017.04.366. Epub 2017 May 1.

PMID:
28473247
8.

Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.

Bonovas S, Fiorino G, Lytras T, Nikolopoulos G, Peyrin-Biroulet L, Danese S.

Aliment Pharmacol Ther. 2017 May;45(9):1179-1192. doi: 10.1111/apt.14023. Epub 2017 Mar 6. Review.

PMID:
28261835
9.

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Moussata D, Allez M, Cazals-Hatem D, Treton X, Laharie D, Reimund JM, Bertheau P, Bourreille A, Lavergne-Slove A, Brixi H, Branche J, Gornet JM, Stefanescu C, Moreau J, Marteau P, Pelletier AL, Carbonnel F, Seksik P, Simon M, Fléjou JF, Colombel JF, Charlois AL, Roblin X, Nancey S, Bouhnik Y, Berger F, Flourié B; the GETAID.

Gut. 2018 Apr;67(4):616-624. doi: 10.1136/gutjnl-2016-311892. Epub 2017 Jan 23.

PMID:
28115492
10.

Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.

Kim SL, Kim SH, Park YR, Liu YC, Kim EM, Jeong HJ, Kim YN, Seo SY, Kim IH, Lee SO, Lee ST, Kim SW.

Mol Cancer Res. 2017 Feb;15(2):141-151. doi: 10.1158/1541-7786.MCR-16-0101. Epub 2016 Nov 14.

11.

Radiographic and endoscopic regression of metastatic gastric cancer to the colon in the setting of 5-aminosalicylic acid use.

Patel YA, McCall SJ, Zhang X, Jaffe T, Shimpi RA.

J Gastrointest Oncol. 2016 Dec;7(6):E88-E92. doi: 10.21037/jgo.2016.05.02.

12.
13.

Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.

Xu J, Tam M, Samaei S, Lerouge S, Barralet J, Stevenson MM, Cerruti M.

Acta Biomater. 2017 Jan 15;48:247-257. doi: 10.1016/j.actbio.2016.10.026. Epub 2016 Oct 18.

PMID:
27769943
14.

Hemangioma of the rectum - How misleading can hematochezia be?

Vitor S, Oliveira Ferreira A, Lopes J, Velosa J.

Rev Esp Enferm Dig. 2016 Aug;108(8):500-1.

15.

Pattern of Inflammation on Surveillance Colonoscopy Does Not Predict Development of Colitis-associated Neoplasia.

Jegadeesan R, Navaneethan U, Gutierrez NG, Venkatesh PG, Hammel JP, Sanaka MR, Shen B.

Inflamm Bowel Dis. 2016 Sep;22(9):2221-8. doi: 10.1097/MIB.0000000000000862.

PMID:
27542134
16.

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.

Cheddani H, Dauchet L, Fumery M, Charpentier C, Marie Bouvier A, Dupas JL, Pariente B, Peyrin-Biroulet L, Savoye G, Gower-Rousseau C.

Am J Gastroenterol. 2016 Oct;111(10):1428-1436. doi: 10.1038/ajg.2016.304. Epub 2016 Aug 2.

PMID:
27481308
17.

Ulcerative colitis associated with nephrotic syndrome after treatment with mesalazine developed into rectal carcinoma: a case study.

Sameshima S, Koketsu S, Okuyama T, Kubota Y, Ono Y, Noie T, Oya M.

World J Surg Oncol. 2016 Jul 22;14(1):192. doi: 10.1186/s12957-016-0950-1.

18.

Colitis cystica profunda: A report of 2 cases with a 15-year follow-up.

Spicakova K, Pueyo BA, de la Piscina PR, Urtasun L, Ganchegui I, Campos A, Estrada S, García-Campos F.

Gastroenterol Hepatol. 2017 Jun - Jul;40(6):406-408. doi: 10.1016/j.gastrohep.2016.04.011. Epub 2016 May 31. English, Spanish. No abstract available.

PMID:
27260634
19.

Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis.

Wiese DM, Horst SN, Brown CT, Allaman MM, Hodges ME, Slaughter JC, Druce JP, Beaulieu DB, Schwartz DA, Wilson KT, Coburn LA.

PLoS One. 2016 May 26;11(5):e0156387. doi: 10.1371/journal.pone.0156387. eCollection 2016.

20.

Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.

Lopez A, Collet-Fenetrier B, Belle A, Peyrin-Biroulet L.

J Dig Dis. 2016 Jun;17(6):383-91. doi: 10.1111/1751-2980.12356.

PMID:
27129893

Supplemental Content

Loading ...
Support Center